An activist investor has reshaped the board, securing the departures of STAAR’s CEO and chair.

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving ...

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

Medtronic will integrate Precision Neuroscience’s Layer 7 cortical interface with its StealthStation surgical navigation ...

The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain ...

The company has committed the cash, half of which it is paying upfront, to buy Integrity Orthopaedics for its rotator cuff ...

The deal would set up Boston Scientific to compete directly with Medtronic in the market for neuromodulation devices that ...

The company unveiled the appointment alongside news of the departure of its chief commercial officer.

Edwards terminated the deal after the Federal Trade Commission moved to block the acquisition due to anticompetitive concerns ...

From insurance coverage questions to M&A and tariffs, here are the top storylines to watch in the medical device space in ...

Johnson & Johnson’s filing comes a month after Medtronic gained U.S. clearance for its Hugo system as competition in the soft ...

The next Medical Device User Fee Amendments, which will set how much the FDA can raise from the industry in fees over a ...